OIRA Conclusion of EO 12866 Regulatory Review

RIN: 1117-AB34         View EO 12866 Meetings	Received Date: 01/23/2012
Title: Establishment of Quotas Required by Controlled Substances Act
Agency/Subagency: DOJ / DEA
Concluded Action: Withdrawn	Concluded Date: 03/21/2012
Publication Date:
Regulatory Flexibility Analysis Required: Undetermined	Small Entities Affected:
Federalism Implications: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
International Impacts: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No
Pandemic Response: Uncollected